Applied Health Economics and Health Policy

Papers
(The TQCC of Applied Health Economics and Health Policy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis323
COVID-19 Pandemic, a War to be Won: Understanding its Economic Implications for Africa188
Willingness to Pay for a COVID-19 Vaccine82
The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data68
Using Insights from Behavioral Economics to Mitigate the Spread of COVID-1960
A Simple Decision Analysis of a Mandatory Lockdown Response to the COVID-19 Pandemic47
Why Only Test Symptomatic Patients? Consider Random Screening for COVID-1932
Disease-Specific Out-of-Pocket Payments, Catastrophic Health Expenditure and Impoverishment Effects in India: An Analysis of National Health Survey Data29
How Many Intensive Care Beds are Justifiable for Hospital Pandemic Preparedness? A Cost-effectiveness Analysis for COVID-19 in Germany27
The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations27
Health Promoting Schools: An Update25
Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward24
Health Financing in Sub-Saharan Africa: From Analytical Frameworks to Empirical Evaluation23
The Effects of School Closures on COVID-19: A Cross-Country Panel Analysis23
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland23
The Cost-Effectiveness of Pulmonary Rehabilitation for COPD in Different Settings: A Systematic Review20
Impact of a Global Pandemic on Health Technology Assessment19
The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review19
The Italian NHS: What Lessons to Draw from COVID-19?19
COVID-19 Vaccine Demand and Financial Incentives19
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options19
The Role of Mental Health on Workplace Productivity: A Critical Review of the Literature18
Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America18
Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines16
Population Norms for SF-6Dv2 and EQ-5D-5L in China16
Systematic Review and Critique of Methods for Economic Evaluation of Digital Mental Health Interventions16
Costs of Illness of Spinal Muscular Atrophy: A Systematic Review16
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/1316
Incidence of Catastrophic Health Expenditure and Its Determinants in Cancer Patients: A Systematic Review and Meta-analysis15
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy14
The Sandbox Approach and its Potential for Use in Health Technology Assessment: A Literature Review14
Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives14
Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India's National Publicly Financed Health Insurance Scheme13
Budget Impact of Microbial Cell-Free DNA Testing Using the Karius® Test as an Alternative to Invasive Procedures in Immunocompromised Patients with Suspected Invasive Fungal Infections13
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature13
Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer12
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom12
Estimating Catastrophic Health Expenditures from Household Surveys: Evidence from Living Standard Measurement Surveys (LSMS)-Integrated Surveys on Agriculture (ISA) from Sub-Saharan Africa12
‘What You See is All There is’: The Importance of Heuristics in Cost-Benefit Analysis (CBA) and Social Return on Investment (SROI) in the Evaluation of Public Health Interventions12
Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations11
EQ-5D-5L Health-State Values for the Mexican Population11
The Health and Productivity Burden of Depression in South Korea11
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C3011
Which Criteria are Considered and How are They Evaluated in Health Technology Assessments? A Review of Methodological Guidelines Used in Western and Asian Countries11
Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?11
Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review11
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations10
Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment10
Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy10
Revisiting the Relationship Between Price Regulation and Pharmaceutical R&D Investment10
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models9
Cost-Utility Analysis of Dapagliflozin Versus Saxagliptin Treatment as Monotherapy or Combination Therapy as Add-on to Metformin for Treating Type 2 Diabetes Mellitus9
National Methodological Guidelines to Conduct Budget Impact Analysis for Health Technology Assessment in India9
The Case for a Temporary COVID-19 Income Tax Levy Now, During the Crisis8
Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?8
The Impact of Financing Health Services on Income Inequality in an Unequal Society: The Case of South Africa8
Systematic Review of the Psychometric Performance of Generic Childhood Multi-attribute Utility Instruments8
Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version7
Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM7
Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD7
Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine”7
Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?7
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon7
EQ-5D-5L Population Norms for Italy7
Approaches to Measure Efficiency in Primary Care: A Systematic Literature Review7
Centralised Pharmaceutical Procurement: Learnings from Six European Countries7
Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results7
Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review7
The Cost Effectiveness of Taxation of Sugary Foods and Beverages: A Systematic Review of Economic Evaluations6
Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study6
Consumers' Preferences and Willingness to Pay for Personalised Nutrition6
Prescription Drug Monitoring Programs and Opioid Prescriptions for Disability Conditions6
UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update6
Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis6
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review6
Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations6
Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment6
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis6
0.047477006912231